Related Experiment Video
Updated: Aug 15, 2026

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
Published on: May 18, 2020
The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol
Raúl Pastor1, Carlos M G Aragon
1Area de Psicobiología, Universitat Jaume I, Castelló, Spain.
Abstract:
Nonspecific blockade of opioid receptors has been found to prevent development of behavioral sensitization to ethanol. Whether this effect is achieved through a specific opioid receptor subtype, however, is not clear. The present study investigated, for the first time, the role of specific opioid receptor subtypes in the development of ethanol-(2.5 g/kg/day; six sessions) induced locomotor sensitization in mice. We confirmed previous results showing that the nonspecific antagonism of opioid receptors (naltrexone; 0-2 mg/kg) prevented the development of behavioral sensitization to ethanol, an effect attained at doses presumed to occupy only mu opioid receptors. This was confirmed by using the selective mu opioid receptor antagonist CTOP (0-1.5 mg/kg), which also blocked sensitization to ethanol. The selective delta receptor antagonist, naltrindole (0-10 mg/kg), however, did not alter sensitization. We further assessed the role of mu opioid receptors in sensitization to ethanol by exploring the involvement of mu(1), mu(1+2), and mu(3) opioid receptor subtypes. Results of these experiments revealed that the blockade of mu(1) (naloxonazine; 0-30 mg/kg) or mu(3) opioid receptors (3-methoxynaltrexone; 0-6 mg/kg) did not prevent locomotor sensitization to ethanol. Using naloxonazine under treatment conditions that block mu(1+2) opioid receptor subtypes we observed a retarded sensitization. The present data suggest that the concurrent inactivation of all mu opioid receptor subtypes may be required to prevent the neural adaptations underlying the development of behavioral sensitization to ethanol. In addition, these results support previous data suggesting a putative role for the mu opioid receptor endogenous ligand, beta-endorphin, and the hypothalamic arcuate nucleus in ethanol sensitization.
Insights
Blocking mu opioid receptors is key to preventing ethanol-induced behavioral sensitization in mice. This suggests that targeting all mu opioid receptor subtypes is necessary to block neural adaptations related to ethanol sensitization.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Opioid receptors play a role in behavioral sensitization to ethanol.
- The specific opioid receptor subtypes involved are not fully understood.
Purpose of the Study:
- To investigate the role of specific opioid receptor subtypes in ethanol-induced locomotor sensitization in mice.
- To determine if mu, delta, or specific mu subtypes are responsible for this effect.
Main Methods:
- Mice were administered ethanol (2.5 g/kg/day for six sessions) to induce locomotor sensitization.
- Various opioid receptor antagonists were used: naltrexone (nonspecific), CTOP (mu-selective), naltrindole (delta-selective), naloxonazine (mu(1)-selective), and 3-methoxynaltrexone (mu(3)-selective).
- Locomotor activity was measured to assess sensitization.
Main Results:
- Nonspecific opioid receptor blockade with naltrexone prevented ethanol sensitization.
- Selective mu opioid receptor antagonist CTOP also blocked sensitization.
- Selective delta receptor antagonist naltrindole had no effect on sensitization.
- Blockade of mu(1) or mu(3) receptors alone did not prevent sensitization.
- Blocking mu(1+2) receptor subtypes with naloxonazine retarded sensitization.
Conclusions:
- Concurrent inactivation of all mu opioid receptor subtypes may be required to prevent neural adaptations underlying ethanol sensitization.
- These findings support a role for the mu opioid receptor and beta-endorphin in ethanol sensitization.
More Related Videos
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners

